Information for consumers
Salbutamol is used in adults and children 4 years of age and older to relieve and prevent bronchospasm (a sudden worsening of shortness of breath and wheezing) due to bronchial asthma, chronic bronchitis or other chronic lung disorders and to prevent bronchospasm caused by exercise.
Some manufacturers have reported shortages of this product on
Drug Shortages Canada because of an increase in demand, and given the medical necessity of salbutamol, related to the current COVID-19 pandemic. At this time, to manage and conserve supply, most patients will receive only one inhaler at a time when they go to refill their prescription.
Health Canada has permitted the exceptional importation of UK-labelled salbutamol to help alleviate the shortage. Both Canadian and UK-labelled salbutamol inhalers are used in a comparable way. Preparation for use instructions for the UK-labelled inhaler are different from the Canadian inhaler. Before using the UK-labelled inhaler for the first time, or if it has not been used for 5 days or more,
release 2 sprays into the air to ensure it is working properly. Follow Canadian dosing recommendations when using UK-labelled salbutamol inhaler
for children 4–11 years of age: maximum 4 sprays (400 mcg salbutamol) per day. The maximum recommended daily dosage on the UK-labelled salbutamol inhaler indicates 8 sprays per day.
Patients should contact their healthcare professional for more details on this new safety information.
Information for healthcare professionals
The UK-labelled salbutamol inhalers have the same active ingredient and are identical in concentration as salbutamol inhalers on the Canadian market, and are used in a comparable way. Healthcare professionals are advised that the preparation for use instructions for the UK-labelled salbutamol inhaler may differ from those for the Canadian inhalers. Before using the UK-labelled salbutamol inhaler for the first time, or if it has not been used for 5 days or more,
2 sprays should be released into the air to ensure it is working properly.
Healthcare professionals are also advised to follow Canadian dosing recommendations when using, prescribing, or dispensing UK-labelled salbutamol inhaler for children 4–11 years of age:
maximum 4 sprays (400 mcg salbutamol) per day. The maximum recommended daily dosage on the UK-labelled salbutamol inhaler indicates 8 sprays per day.
Pharmacists and other healthcare professionals are reminded to:
-
Inform patients that they are receiving a UK-labelled product.
-
Print this communication and make it available to patients and caregivers upon dispensing the UK-labelled product.
-
Review the preparation for use instructions for the UK-labelled inhaler with the patient when dispensing this product.
-
Remind caregivers that the maximum recommended daily dose is 4 sprays for children 4-11 years of age.
-
Supply only one inhaler at a time when patients go to refill their prescription, to manage and conserve supply.
-
Consult the Canadian product monograph for prescribing information as well as important safety information on salbutamol inhalers at Health Canada's Drug Product Database.
Action taken by Health Canada
Health Canada is communicating this important safety information to healthcare professionals and Canadians via the Recalls and Safety Alerts Database on the Healthy Canadians Web Site. This communication will be further distributed through the MedEffect™ e-Notice email notification system as well as social media channels including LinkedIn and Twitter.